Neonates Clinical Trial
Official title:
Utility of Spontaneous Breathing Trial (SBT) Using ET-CPAP, in Predicting Extubation Failure in Neonates
Intubation and ventilation are lifesaving interventions in the neonatal intensive care unit (ICU), especially among preterm, low birth weight babies. However, timely extubation is also necessary. The decision to extubate usually depends on clinical judgement, appropriate blood gas prior to extubation and low ventilator parameters. Approximately 40 % of babies' extubated on the above criteria require re-intubation, suggesting that current methods to predict extubation failure are insufficient. . Spontaneous breathing trial (SBT) has been predominantly used in infants and children to access the readiness for extubation. Few studies in premature neonates have also shown good sensitivity and specificity in predicting extubation success. However its significance in our population is yet to be determined. We aim to use this for both our preterm and term babies and if results are significant we plan to include this as our routine pre extubation criteria.
Intubation and ventilation are lifesaving interventions in the neonatal intensive care unit
(ICU), especially among preterm, low birth weight babies. However, timely extubation is also
necessary, in order to prevent adverse effects of prolonged intubation, such as iatrogenic
pneumothorax, superadded bacterial infections and colonization, subglottic injury and
bronchopulmonary dysplasia1,2.
For extubation to be successful, baby should maintain hemodynamic stability and O2
saturation for at least 48 hours post-extubation. So far there are no standard guidelines,
especially in low resource countries such as ours, to predict successful extubation. The
decision to extubate usually depends on clinical judgement, appropriate blood gas prior to
extubation and low ventilator parameters3. Intensivists may vary in their experience and
training, resulting in a large variation in the timing and outcome of extubation.
Research from high income settings indicates that approximately 40 % of babies extubated on
the above criteria require re-intubation, suggesting that current methods to predict
extubation failure are insufficient.3 Readiness for extubation can be objectively measured
by observing pulmonary functions, respiratory muscle strength, respiratory drive, ventilator
flow volumes and gas exchange.5,6 Re-intubation causes prolonged hospital stay, adversely
effects the family, and results in undesirable effects on the neonate4 . Therefore accurate
prediction of extubation failure in neonates is a high priority. Spontaneous breathing trial
(SBT) has been predominantly used in infant and children to access the readiness for
extubation . Few studies in premature neonates have also shown good sensitivity and
specificity in predicting extubation sucess7.However its significance in our population is
yet to be determined. We aim to use this for both our preterm and term babies and if results
are significant we plan to include this as our routine pre extubation criteria.
Primary Objective:
To evaluate the usefulness of SBT, in predicting extubation failure among neonates admitted
to a NICU in a tertiary care hospital in Karachi, Pakistan.
Secondary Objective:
1. To evaluate the usefulness of ratio of spontaneous expired minute ventilation(VE)
during ET CPAP to VE during mechanical ventilation (V˙E ratio , )in predicting
extubation failure among neonates admitted to a NICU in a tertiary care hospital in
Karachi, Pakistan.
2. To evaluate the usefulness of VE during ETCPAP, in predicting extubation failure among
neonates admitted to a NICU in a tertiary care hospital in Karachi, Pakistan.
Study Design: Prospective validation study Study Setting: NICU, AKU Duration of study: 12
months Study Population: Neonates admitted to a tertiary care NICU in a low resource setting
Operational definitions:
1. Expired Tidal volume(Vte) : volume of gas (ml) which moves out of the lung with each
breath.
2. Spontaneous Expired Minute ventilation(VE) : amount of gas spontaneously exhaled from
lungs in one minute. This is a product of Vte and respiratory rate. It is displayed in
real time on SLE 5000 ventilator. Normal values for full term babies is 200-400
ml/kg/min whereas 200-300 ml /kg/min for preterm babies.
3. VE Ratio: Et cpapVE/Vent VE Sampling technique: Consecutive sampling Sample size:
Assuming SBT to have 95% sensitivity and 73% specificity for predicting extubation
sucess7 , and presuming that 30% of neonates will fail extubation, we will require 45
neonates in each group to obtain 95% CIs of ±3%. The sample size will be inflated by
20% to accommodate for differences in re-intubation practice. Therefore 55 neonates in
each group will be enrolled in the study. This sample size is sufficient to also detect
a difference of 1 SD in mean VE in the group failing extubation, assuming an overall
mean VE of 300ml/kg/min (power 80%and twotail αof 0.05).
Study Methods:
Identification and recruitment of neonates:
An NICU fellow not involved in the clinical management of the baby will maintain a log of
all neonates who are planned to be extubated. Eligibility assessment will be done by the
fellow who will then approach the neonate's family for consent. Care will be taken to ensure
that consent is voluntary. Refusal of consent will not lead to any change in the management.
A baseline questionnaire will be filled, including demographic information such as post
-natal age, gender, gestational age, current weight etc. Information related to the clinical
indication of extubation, other medications given will be recorded. Eligible candidates will
be divided into two groups of <1.5kg weight and >1.5kg weight. Separate log will be
maintained for both groups. Total of 55 enrolments will be made in each group.
Data collection:
Will be according to SOP. Questionnaires are attached.
Index Maneuver:
After enrolment, Nicu SBT study fellow will observe and record clinical data and patient
demographics on a predefined proforma. Vitals, including heart rate, respiratory rate,
ventilator parameters and respiratory volumes will be recorded by same observer for 3
minutes at 30 second intervals.
After 3 minutes the baby will be shifted to ET CPAP mode on the same ventilator and the same
parameters will be rerecorded at 30 sec interval for 3 minutes as done previously. A
regularly serviced and authorized stop watch will be used to monitor the time and all
parameters will be recorded from the Mindray (IPM12) monitors and SLE 5000 ventilator. The
clinical teams caring for the patients will not be present during the maneuver and all the
babies will be extubated as per the primary teams plan.
Criteria for stopping the index maneuver:
Bradycardia (Heart rate <100bpm) for >15 seconds and/or oxygen Saturation of <85% even after
15 % increase in Fi02 from the baseline.
Follow-up and outcomes:
Outcomes of extubation will be recorded separately after 48 hours. The reasons for
re-intubation will also be recorded.
Blinding:
SBT maneuver will be performed by a fellow not involved in the clinical team. The clinical
team will be blinded to the results of the SBT. The success and failure of SBT will be
determined by the principal investigator, who will be blinded to the outcome of the
extubation, after the completion of the study
SBT Results: SBT will be labeled as failed if the criteria for stopping the index maneuver
were applied.
Analysis plan:
Descriptive analysis for both groups will be performed for continuous variables like age,
weight , gestational age , chronological age using means with SD and medians with
interquartile ranges as appropriate. For categorical variables e.g. gender, frequencies and
proportions will be reported. Multiple logistic regression will be done to identify factors
predicting SBT failure in each group. P value of < 0.05 will be taken as significant..
Sensitivity, specificity, PPV, NPV, LR will be calculated using area under curve (AUC).
Subgroup analysis for secondary outcomes will be performed in different gestational age and
weight categories.
Continuous outcomes will be compared using student's t test when normally distributed and by
Mann-whitney U test when skewed. Categorical data will be assessed using the chi square test
and fisher two tailed exact test where indicated. The ability of the outcome (SBT, VE, VE
ratio) variables to accurately discriminate between successful and failed extubation will be
assessed using receiver operating curves(ROC) .
ETHICAL CONSIDERATIONS
Informed Consent The informed consent will be confirmed with a signature or thumbprint by
the parent or the authorized guardian of the child. In the absence of a signature, a witness
(other than the member of the research team obtaining consent) will be asked to sign.
Finally, the member of the research team obtaining consent will sign this form.
Safety and Risks There is a potential risk of transient hemodynamic instability when
performing the SBT. That is why, safety net is in place to record heart rate and O2
saturation every 30 seconds. A trained nurse and neonatal fellow trained in NRP will be
available at the bedside during the procedure. The fellow performing the procedure is year
two with NRP certification. He will further be trained to immediately revert to the
ventilation mode if HR < 100 beats per minute for > 15 seconds and increase in Oxygen
requirement O2. This has been practiced in another study in an NICU by PG Davis et al in
2006 and shown to have no adverse effects7.
Vulnerable Populations Study population is neonates because the study involves optimizing
NICU care of neonates. Consent will be taken in Urdu to ensure that the potential
participant understands the research. Extra protection will be in place to ensure voluntary
participation. It will be explained that participation is voluntary and can be terminated by
the participant at any time without reason and without any penalty. If the potential
participant has any questions, they will be answered in their native language to ensure that
they understand the research and their potential role in it. The study personnel will not
influence the clinical team's decisions in caring for the neonate.
Confidentiality To ensure privacy, all the interviews will take place in a separate room.
Hard copies of the study-related forms will be stored in a locked cabinet in a storage room
under supervision of the principal investigators. Only approved study personnel will have
access to this information. After completion of the study, identifier information will be
stripped and only study IDs will be used during analysis. All identifier information will be
delinked and identifier information will be stored under lock and key.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05073549 -
Optimizing Antibiotic Use in Neonatal Intensive Care Units in China
|
N/A | |
Completed |
NCT00702988 -
Pregnancy & Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 (Study 38827)(P06056)(COMPLETED)
|
||
Completed |
NCT03647293 -
Less Pain in Neonates During Central Lines Insertion
|
N/A | |
Recruiting |
NCT01075490 -
Neonatal Spinal Anesthesia: Effects of the Addition of Clonidine
|
Phase 4 | |
Completed |
NCT00724789 -
Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)
|
||
Completed |
NCT00702338 -
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)
|
||
Completed |
NCT01348295 -
Pediatric Ventilatory Care in Finland 2010
|
N/A | |
Not yet recruiting |
NCT03047876 -
Brain Vascular Reactivity to Hypothermic Circulatory Arrest With Antegrade Cerebral Perfusion During Aortic Arch Surgery
|
||
Terminated |
NCT01181596 -
NICU-TECH RM9L-RS Probe ME Feasibility Study
|
||
Completed |
NCT05242107 -
Omega-3 on Lipid Profile and Serum Leptin Level n Neonates With Intrauterine Growth Restriction
|
N/A | |
Completed |
NCT00703014 -
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)
|
||
Completed |
NCT03604094 -
Ultrasound Measurement of RIJV in Patients Between 0-2 Years
|
||
Completed |
NCT00890344 -
Body Composition Assessment in Healthy Full-term Neonates by Anthropometry, Air Displacement Plethysmography and Multiple-frequency Bio-impedance Analysis
|
N/A | |
Completed |
NCT00702234 -
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)
|
||
Recruiting |
NCT06352606 -
Spinal and General Anesthesia in Neonates Undergoing Herniorrhaphy
|
N/A | |
Completed |
NCT00702624 -
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)
|
||
Completed |
NCT00702520 -
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)
|